Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03077633Phase 3Withdrawn
Phase 3, randomised, open-label trial (2 arms), sponsored by Pediatrix Medical Group. Primary endpoints: Preterm birth before 32 weeks and Adverse perinatal outcome. Planned start Oct 2017; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03077633.